Global Plasmid Market Research Report 2023

Plasmid Market

The global Plasmid market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Plasmid in Transfection is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Plasmid include Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics and Copernicus Therapeutics Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Plasmid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid.

The Plasmid market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Plasmid market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Plasmid companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Plasmid Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Plasmid Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 F-Plasmids

1.2.3 Col Plasmids

1.2.4 Resistance Plasmids

1.2.5 Cryptic Plasmids

1.2.6 Degradative Plasmids

1.2.7 Virulence Plasmids

1.3 Market by Application

1.3.1 Global Plasmid Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Transfection

1.3.3 Recombinant DNA Technology

1.3.4 Gene Therapy

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Plasmid Market Perspective (2018-2029)

2.2 Plasmid Growth Trends by Region

2.2.1 Global Plasmid Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Plasmid Historic Market Size by Region (2018-2023)

2.2.3 Plasmid Forecasted Market Size by Region (2024-2029)

2.3 Plasmid Market Dynamics

2.3.1 Plasmid Industry Trends

2.3.2 Plasmid Market Drivers

2.3.3 Plasmid Market Challenges

2.3.4 Plasmid Market Restraints

3.1 Global Top Plasmid Players by Revenue

3.1.1 Global Top Plasmid Players by Revenue (2018-2023)

3.1.2 Global Plasmid Revenue Market Share by Players (2018-2023)

3.2 Global Plasmid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Plasmid Revenue

3.4 Global Plasmid Market Concentration Ratio

3.4.1 Global Plasmid Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Plasmid Revenue in 2022

3.5 Plasmid Key Players Head office and Area Served

3.6 Key Players Plasmid Product Solution and Service

3.7 Date of Enter into Plasmid Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Plasmid Historic Market Size by Type (2018-2023)

4.2 Global Plasmid Forecasted Market Size by Type (2024-2029)

5.1 Global Plasmid Historic Market Size by Application (2018-2023)

5.2 Global Plasmid Forecasted Market Size by Application (2024-2029)

6.1 North America Plasmid Market Size (2018-2029)

6.2 North America Plasmid Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Plasmid Market Size by Country (2018-2023)

6.4 North America Plasmid Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Plasmid Market Size (2018-2029)

7.2 Europe Plasmid Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Plasmid Market Size by Country (2018-2023)

7.4 Europe Plasmid Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Plasmid Market Size (2018-2029)

8.2 Asia-Pacific Plasmid Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Plasmid Market Size by Region (2018-2023)

8.4 Asia-Pacific Plasmid Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Plasmid Market Size (2018-2029)

9.2 Latin America Plasmid Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Plasmid Market Size by Country (2018-2023)

9.4 Latin America Plasmid Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Plasmid Market Size (2018-2029)

10.2 Middle East & Africa Plasmid Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Plasmid Market Size by Country (2018-2023)

10.4 Middle East & Africa Plasmid Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Aldevron

11.1.1 Aldevron Company Detail

11.1.2 Aldevron Business Overview

11.1.3 Aldevron Plasmid Introduction

11.1.4 Aldevron Revenue in Plasmid Business (2018-2023)

11.1.5 Aldevron Recent Development

11.2 GenScript

11.2.1 GenScript Company Detail

11.2.2 GenScript Business Overview

11.2.3 GenScript Plasmid Introduction

11.2.4 GenScript Revenue in Plasmid Business (2018-2023)

11.2.5 GenScript Recent Development

11.3 PlasmidFactory GmbH & Co. KG

11.3.1 PlasmidFactory GmbH & Co. KG Company Detail

11.3.2 PlasmidFactory GmbH & Co. KG Business Overview

11.3.3 PlasmidFactory GmbH & Co. KG Plasmid Introduction

11.3.4 PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2018-2023)

11.3.5 PlasmidFactory GmbH & Co. KG Recent Development

11.4 VGXI Inc.

11.4.1 VGXI Inc. Company Detail

11.4.2 VGXI Inc. Business Overview

11.4.3 VGXI Inc. Plasmid Introduction

11.4.4 VGXI Inc. Revenue in Plasmid Business (2018-2023)

11.4.5 VGXI Inc. Recent Development

11.5 Oxford Genetics Ltd.

11.5.1 Oxford Genetics Ltd. Company Detail

11.5.2 Oxford Genetics Ltd. Business Overview

11.5.3 Oxford Genetics Ltd. Plasmid Introduction

11.5.4 Oxford Genetics Ltd. Revenue in Plasmid Business (2018-2023)

11.5.5 Oxford Genetics Ltd. Recent Development

11.6 Applied StemCell

11.6.1 Applied StemCell Company Detail

11.6.2 Applied StemCell Business Overview

11.6.3 Applied StemCell Plasmid Introduction

11.6.4 Applied StemCell Revenue in Plasmid Business (2018-2023)

11.6.5 Applied StemCell Recent Development

11.7 Altogen Biosystems

11.7.1 Altogen Biosystems Company Detail

11.7.2 Altogen Biosystems Business Overview

11.7.3 Altogen Biosystems Plasmid Introduction

11.7.4 Altogen Biosystems Revenue in Plasmid Business (2018-2023)

11.7.5 Altogen Biosystems Recent Development

11.8 Cobra Biologics

11.8.1 Cobra Biologics Company Detail

11.8.2 Cobra Biologics Business Overview

11.8.3 Cobra Biologics Plasmid Introduction

11.8.4 Cobra Biologics Revenue in Plasmid Business (2018-2023)

11.8.5 Cobra Biologics Recent Development

11.9 Copernicus Therapeutics Inc.

11.9.1 Copernicus Therapeutics Inc. Company Detail

11.9.2 Copernicus Therapeutics Inc. Business Overview

11.9.3 Copernicus Therapeutics Inc. Plasmid Introduction

11.9.4 Copernicus Therapeutics Inc. Revenue in Plasmid Business (2018-2023)

11.9.5 Copernicus Therapeutics Inc. Recent Development

11.10 Takara Bio

11.10.1 Takara Bio Company Detail

11.10.2 Takara Bio Business Overview

11.10.3 Takara Bio Plasmid Introduction

11.10.4 Takara Bio Revenue in Plasmid Business (2018-2023)

11.10.5 Takara Bio Recent Development

11.11 InvivoGen

11.11.1 InvivoGen Company Detail

11.11.2 InvivoGen Business Overview

11.11.3 InvivoGen Plasmid Introduction

11.11.4 InvivoGen Revenue in Plasmid Business (2018-2023)

11.11.5 InvivoGen Recent Development

11.12 Miltenyi Biotec

11.12.1 Miltenyi Biotec Company Detail

11.12.2 Miltenyi Biotec Business Overview

11.12.3 Miltenyi Biotec Plasmid Introduction

11.12.4 Miltenyi Biotec Revenue in Plasmid Business (2018-2023)

11.12.5 Miltenyi Biotec Recent Development

11.13 Medigene Sdn Bhd

11.13.1 Medigene Sdn Bhd Company Detail

11.13.2 Medigene Sdn Bhd Business Overview

11.13.3 Medigene Sdn Bhd Plasmid Introduction

11.13.4 Medigene Sdn Bhd Revenue in Plasmid Business (2018-2023)

11.13.5 Medigene Sdn Bhd Recent Development

11.14 MaxCyte Inc.

11.14.1 MaxCyte Inc. Company Detail

11.14.2 MaxCyte Inc. Business Overview

11.14.3 MaxCyte Inc. Plasmid Introduction

11.14.4 MaxCyte Inc. Revenue in Plasmid Business (2018-2023)

11.14.5 MaxCyte Inc. Recent Development

11.15 Mirus Bio LLC

11.15.1 Mirus Bio LLC Company Detail

11.15.2 Mirus Bio LLC Business Overview

11.15.3 Mirus Bio LLC Plasmid Introduction

11.15.4 Mirus Bio LLC Revenue in Plasmid Business (2018-2023)

11.15.5 Mirus Bio LLC Recent Development

11.16 MolMed S.p.A.

11.16.1 MolMed S.p.A. Company Detail

11.16.2 MolMed S.p.A. Business Overview

11.16.3 MolMed S.p.A. Plasmid Introduction

11.16.4 MolMed S.p.A. Revenue in Plasmid Business (2018-2023)

11.16.5 MolMed S.p.A. Recent Development

11.17 GenePharma

11.17.1 GenePharma Company Detail

11.17.2 GenePharma Business Overview

11.17.3 GenePharma Plasmid Introduction

11.17.4 GenePharma Revenue in Plasmid Business (2018-2023)

11.17.5 GenePharma Recent Development

11.18 Polyplus Transfection

11.18.1 Polyplus Transfection Company Detail

11.18.2 Polyplus Transfection Business Overview

11.18.3 Polyplus Transfection Plasmid Introduction

11.18.4 Polyplus Transfection Revenue in Plasmid Business (2018-2023)

11.18.5 Polyplus Transfection Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Plasmid Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of F-Plasmids

    Table 3. Key Players of Col Plasmids

    Table 4. Key Players of Resistance Plasmids

    Table 5. Key Players of Cryptic Plasmids

    Table 6. Key Players of Degradative Plasmids

    Table 7. Key Players of Virulence Plasmids

    Table 8. Global Plasmid Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Plasmid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Plasmid Market Size by Region (2018-2023) & (US$ Million)

    Table 11. Global Plasmid Market Share by Region (2018-2023)

    Table 12. Global Plasmid Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 13. Global Plasmid Market Share by Region (2024-2029)

    Table 14. Plasmid Market Trends

    Table 15. Plasmid Market Drivers

    Table 16. Plasmid Market Challenges

    Table 17. Plasmid Market Restraints

    Table 18. Global Plasmid Revenue by Players (2018-2023) & (US$ Million)

    Table 19. Global Plasmid Market Share by Players (2018-2023)

    Table 20. Global Top Plasmid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid as of 2022)

    Table 21. Ranking of Global Top Plasmid Companies by Revenue (US$ Million) in 2022

    Table 22. Global 5 Largest Players Market Share by Plasmid Revenue (CR5 and HHI) & (2018-2023)

    Table 23. Key Players Headquarters and Area Served

    Table 24. Key Players Plasmid Product Solution and Service

    Table 25. Date of Enter into Plasmid Market

    Table 26. Mergers & Acquisitions, Expansion Plans

    Table 27. Global Plasmid Market Size by Type (2018-2023) & (US$ Million)

    Table 28. Global Plasmid Revenue Market Share by Type (2018-2023)

    Table 29. Global Plasmid Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 30. Global Plasmid Revenue Market Share by Type (2024-2029)

    Table 31. Global Plasmid Market Size by Application (2018-2023) & (US$ Million)

    Table 32. Global Plasmid Revenue Market Share by Application (2018-2023)

    Table 33. Global Plasmid Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 34. Global Plasmid Revenue Market Share by Application (2024-2029)

    Table 35. North America Plasmid Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. North America Plasmid Market Size by Country (2018-2023) & (US$ Million)

    Table 37. North America Plasmid Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Europe Plasmid Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Europe Plasmid Market Size by Country (2018-2023) & (US$ Million)

    Table 40. Europe Plasmid Market Size by Country (2024-2029) & (US$ Million)

    Table 41. Asia-Pacific Plasmid Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Asia-Pacific Plasmid Market Size by Region (2018-2023) & (US$ Million)

    Table 43. Asia-Pacific Plasmid Market Size by Region (2024-2029) & (US$ Million)

    Table 44. Latin America Plasmid Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Latin America Plasmid Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Latin America Plasmid Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Middle East & Africa Plasmid Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 48. Middle East & Africa Plasmid Market Size by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Plasmid Market Size by Country (2024-2029) & (US$ Million)

    Table 50. Aldevron Company Detail

    Table 51. Aldevron Business Overview

    Table 52. Aldevron Plasmid Product

    Table 53. Aldevron Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 54. Aldevron Recent Development

    Table 55. GenScript Company Detail

    Table 56. GenScript Business Overview

    Table 57. GenScript Plasmid Product

    Table 58. GenScript Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 59. GenScript Recent Development

    Table 60. PlasmidFactory GmbH & Co. KG Company Detail

    Table 61. PlasmidFactory GmbH & Co. KG Business Overview

    Table 62. PlasmidFactory GmbH & Co. KG Plasmid Product

    Table 63. PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 64. PlasmidFactory GmbH & Co. KG Recent Development

    Table 65. VGXI Inc. Company Detail

    Table 66. VGXI Inc. Business Overview

    Table 67. VGXI Inc. Plasmid Product

    Table 68. VGXI Inc. Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 69. VGXI Inc. Recent Development

    Table 70. Oxford Genetics Ltd. Company Detail

    Table 71. Oxford Genetics Ltd. Business Overview

    Table 72. Oxford Genetics Ltd. Plasmid Product

    Table 73. Oxford Genetics Ltd. Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 74. Oxford Genetics Ltd. Recent Development

    Table 75. Applied StemCell Company Detail

    Table 76. Applied StemCell Business Overview

    Table 77. Applied StemCell Plasmid Product

    Table 78. Applied StemCell Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 79. Applied StemCell Recent Development

    Table 80. Altogen Biosystems Company Detail

    Table 81. Altogen Biosystems Business Overview

    Table 82. Altogen Biosystems Plasmid Product

    Table 83. Altogen Biosystems Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 84. Altogen Biosystems Recent Development

    Table 85. Cobra Biologics Company Detail

    Table 86. Cobra Biologics Business Overview

    Table 87. Cobra Biologics Plasmid Product

    Table 88. Cobra Biologics Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 89. Cobra Biologics Recent Development

    Table 90. Copernicus Therapeutics Inc. Company Detail

    Table 91. Copernicus Therapeutics Inc. Business Overview

    Table 92. Copernicus Therapeutics Inc. Plasmid Product

    Table 93. Copernicus Therapeutics Inc. Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 94. Copernicus Therapeutics Inc. Recent Development

    Table 95. Takara Bio Company Detail

    Table 96. Takara Bio Business Overview

    Table 97. Takara Bio Plasmid Product

    Table 98. Takara Bio Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 99. Takara Bio Recent Development

    Table 100. InvivoGen Company Detail

    Table 101. InvivoGen Business Overview

    Table 102. InvivoGen Plasmid Product

    Table 103. InvivoGen Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 104. InvivoGen Recent Development

    Table 105. Miltenyi Biotec Company Detail

    Table 106. Miltenyi Biotec Business Overview

    Table 107. Miltenyi Biotec Plasmid Product

    Table 108. Miltenyi Biotec Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 109. Miltenyi Biotec Recent Development

    Table 110. Medigene Sdn Bhd Company Detail

    Table 111. Medigene Sdn Bhd Business Overview

    Table 112. Medigene Sdn Bhd Plasmid Product

    Table 113. Medigene Sdn Bhd Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 114. Medigene Sdn Bhd Recent Development

    Table 115. MaxCyte Inc. Company Detail

    Table 116. MaxCyte Inc. Business Overview

    Table 117. MaxCyte Inc. Plasmid Product

    Table 118. MaxCyte Inc. Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 119. MaxCyte Inc. Recent Development

    Table 120. Mirus Bio LLC Company Detail

    Table 121. Mirus Bio LLC Business Overview

    Table 122. Mirus Bio LLC Plasmid Product

    Table 123. Mirus Bio LLC Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 124. Mirus Bio LLC Recent Development

    Table 125. MolMed S.p.A. Company Detail

    Table 126. MolMed S.p.A. Business Overview

    Table 127. MolMed S.p.A. Plasmid Product

    Table 128. MolMed S.p.A. Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 129. MolMed S.p.A. Recent Development

    Table 130. GenePharma Company Detail

    Table 131. GenePharma Business Overview

    Table 132. GenePharma Plasmid Product

    Table 133. GenePharma Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 134. GenePharma Recent Development

    Table 135. Polyplus Transfection Company Detail

    Table 136. Polyplus Transfection Business Overview

    Table 137. Polyplus Transfection Plasmid Product

    Table 138. Polyplus Transfection Revenue in Plasmid Business (2018-2023) & (US$ Million)

    Table 139. Polyplus Transfection Recent Development

    Table 140. Research Programs/Design for This Report

    Table 141. Key Data Information from Secondary Sources

    Table 142. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Plasmid Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Plasmid Market Share by Type: 2022 VS 2029

    Figure 3. F-Plasmids Features

    Figure 4. Col Plasmids Features

    Figure 5. Resistance Plasmids Features

    Figure 6. Cryptic Plasmids Features

    Figure 7. Degradative Plasmids Features

    Figure 8. Virulence Plasmids Features

    Figure 9. Global Plasmid Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Plasmid Market Share by Application: 2022 VS 2029

    Figure 11. Transfection Case Studies

    Figure 12. Recombinant DNA Technology Case Studies

    Figure 13. Gene Therapy Case Studies

    Figure 14. Others Case Studies

    Figure 15. Plasmid Report Years Considered

    Figure 16. Global Plasmid Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 17. Global Plasmid Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Plasmid Market Share by Region: 2022 VS 2029

    Figure 19. Global Plasmid Market Share by Players in 2022

    Figure 20. Global Top Plasmid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid as of 2022)

    Figure 21. The Top 10 and 5 Players Market Share by Plasmid Revenue in 2022

    Figure 22. North America Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. North America Plasmid Market Share by Country (2018-2029)

    Figure 24. United States Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Plasmid Market Share by Country (2018-2029)

    Figure 28. Germany Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Plasmid Market Share by Region (2018-2029)

    Figure 36. China Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Japan Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. South Korea Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. India Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Australia Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Plasmid Market Share by Country (2018-2029)

    Figure 44. Mexico Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Brazil Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Plasmid Market Share by Country (2018-2029)

    Figure 48. Turkey Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Plasmid Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Aldevron Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 51. GenScript Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 52. PlasmidFactory GmbH & Co. KG Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 53. VGXI Inc. Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 54. Oxford Genetics Ltd. Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 55. Applied StemCell Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 56. Altogen Biosystems Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 57. Cobra Biologics Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 58. Copernicus Therapeutics Inc. Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 59. Takara Bio Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 60. InvivoGen Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 61. Miltenyi Biotec Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 62. Medigene Sdn Bhd Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 63. MaxCyte Inc. Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 64. Mirus Bio LLC Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 65. MolMed S.p.A. Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 66. GenePharma Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 67. Polyplus Transfection Revenue Growth Rate in Plasmid Business (2018-2023)

    Figure 68. Bottom-up and Top-down Approaches for This Report

    Figure 69. Data Triangulation

    Figure 70. Key Executives Interviewed